CytRx Corporation (NASDAQ:CYTR) announced that Shanta Chawla, M.D.
CytRx Corporation (NASDAQ:CYTR) have a smile on their faces Thursday, after the drug maker announced an update on the regulatory pathway for a New …
Fund manager Hal Mintz of the $1.8 billion Sabby Capital fund has made some intriguing portfolio shifts in Q1, including slashing the fund’s …
CytRx Corporation (NASDAQ:CYTR) shares tank 20% to $0.55 in pre-market trading Friday, after the drug maker announced that it has priced a public offering of approximately …
Today, shareholders of CytRx Corporation (NASDAQ:CYTR) woke up to a nice pop in the value of their shares, after the drug maker announced …
CytRx Corporation (NASDAQ:CYTR) announced that, in response to a request from the company, the U.S.
CytRx Corporation (NASDAQ:CYTR) has announced the appointment of Daniel Levitt, M.D.
CytRx Corporation (NASDAQ:CYTR) investors are heading for the hills after the oncology drug maker announced that it has entered into securities purchase agreements …
CytRx Corporation (NASDAQ:CYTR) investors should be smiling from ear to ear today, after the drug make announced positive updated results from its pivotal Phase …
CytRx Corporation (NASDAQ:CYTR) presented a poster with updated interim results from its on-going Phase 1b/2 trial of aldoxorubicin in combination with ifosfamide/mesna in …
